Hyperimmune immunoglobulin from human plasma vs saline placebo
Serious adverse events up to day 28 (data available only as a composite of serious adverse events or death up to day 28) · individuals with moderate or severe COVID‐19
Hyperimmune immunoglobulin from human plasma showed no clear difference in serious adverse events up to day 28 (data available only as a… compared with saline placebo (low certainty).
1 finding from 1 review
- RR 0.72 [0.45, 1.14]Studies not reportedLow